Medicines are of great value to health care and society. ZonMw research into existing medicines is directed towards their more effective, more efficient, and safer use in day-to-day health care. Widespread dissemination and practical application of the generated knowledge is crucial to delivering health benefits to patients, improving the quality of care, and saving unnecessary costs.
The optimal use of existing medicines is an innovative area of work that shows great promise for the coming years.
For various reasons, we have been forced to postpone two deadlines for the current Veni round by one month. This concerns the deadline for informing the ZonMw applicants about the intended decision concerning their Veni pre-proposals and the deadline for submitting a full proposal. The period between the intended decision and the deadline for submission of a full proposal therefore remains the same, namely eight weeks. The deadline for the final...
The consortium consisting of 32 partner institutions from the three Joint Programming Initiatives (JPIs) on Water, Oceans and Antimicrobial Resistance (AMR) has been invited to sign the Grant Agreement.
Six consortia with top researchers from different Dutch universities have received a total of 113.8 million euros to carry out scientific research programmes in the coming years. The Minister for Education, Culture and Science (OCW), Ingrid van Engelshoven, made these funds available for research consortia that are among the best in the world in their field in carrying out groundbreaking research.
Researchers from Leiden University Medical Center (LUMC) and TU Delft have developed a method for resetting a disrupted heart rhythm. They do that with gene therapy and a tiny, implantable LED lamp. The collaboration between researchers from Leiden and Delft is the unforeseen outcome of a Vidi project from ZonMw.
